Eiji Yoshihara
Institution Name:
Lundquist Institute for Biomedical Innovation at Harbor - UC
Total Awards:
1
Award Value:
$250,000
Awards as PI
Program Type | Institution | Grant Title | Award Value |
---|---|---|---|
Quest - Discovery Stage Research Projects | Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center | Dual angiogenic and immunomodulating nanotechnology for subcutaneous stem cell derived islet transplantation for the treatment of diabetes | $250,000 |
Total: $250,000.00 |
Publications
- Front Endocrinol (Lausanne) 2021 Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes. (PubMed: 34447354)
- Front Endocrinol (Lausanne) 2021 Advances in Pancreatic Islet Transplantation Sites for the Treatment of Diabetes. (PubMed: 34589059)
- Front Cell Dev Biol 2022 Adapting Physiology in Functional Human Islet Organogenesis. (PubMed: 35557947)
- Int J Mol Sci 2022 Stem Cell-Derived Islets for Type 2 Diabetes. (PubMed: 35563490)
- Gastroenterology 2022 Estrogen-Related Receptor gamma Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism. (PubMed: 35461826)